Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v3-EN
Language English English
Date Updated 2018-01-02 2018-01-02
Drug Identification Number 02194376 02194376
Brand name IMMUCYST IMMUCYST
Common or Proper name Bacillus Calmette-Guérin (BCG), substrain Connaught Bacillus Calmette-Guérin (BCG), substrain Connaught
Company Name SANOFI PASTEUR LIMITED SANOFI PASTEUR LIMITED
Ingredients BACILLUS CALMETTE-GUERIN BACILLUS CALMETTE-GUERIN
Strength(s) 81MG 81MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration INTRAVESICAL INTRAVESICAL
Packaging size 1 x 81 mg vial (1 Treatment) 1 x 81 mg vial (1 Treatment)
ATC code L03AX L03AX
ATC description IMMUNOSTIMULANTS IMMUNOSTIMULANTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-01-01 2018-01-01
Actual discontinuation date 2018-01-01 2018-01-01
Remaining supply date 2017-12-31 2017-12-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments The production of IMMUCYST® has been discontinued and supply to the Canadian market will be discontinued as of January 01, 2018. The production of IMMUCYST® has been discontinued and supply to the Canadian market will be discontinued as of January 01, 2018.
Health Canada comments